Skip to content
Screener

Opko Health OPK Q2 2025 earnings

Reported July 31, 2025 · After market close

Revenue$156.8MMiss by $8.9M
EPS-$0.19Miss by $0.07
Revenue estimate$165.7M
EPS estimate-$0.12

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$136.6M
EPS estimate-$0.07

Financials

Q2 2025

Income statement

See full
Revenue$156.8M-13.9%
Gross profit$49.4M-4.4%
Operating income-$60.0M+2.7%
Net income-$148.4M-1,340%
EPS (diluted)-$0.19-1,800%

Balance sheet

See full
Total debt$54.0M-21.9%
Total equity$1.3B-7.1%
Total assets$2.0B-0.3%

Cash flow

See full
Operating cash flow-$83.4M-216%
CapEx$3.3M-54.5%
Free cash flow-$86.7M-158%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.02B+15.8%
Enterprise value$1.08B+18.1%
P/S1.5×+0.3×

Profitability

See full
Gross margin32.7%-2.6pp
Operating margin-34.3%—
Net margin-26.7%-4.7pp
FCF margin-39%—

Returns & leverage

See full
Return on equity-13.2%-2.3pp
Debt / equity0×0.0×
Current ratio3.4×+1.8×

Segments

By product

See full
Transfer Of Intellectual Property And Other$15.0M+21.6%

FAQ

When did Opko Health report Q2 2025 earnings?
Opko Health (OPK) reported Q2 2025 earnings on July 31, 2025 after market close.
What were Opko Health's Q2 2025 revenue and EPS?
Opko Health reported revenue of $156.8M and eps of $-0.19 for Q2 2025.
Did Opko Health beat estimates in Q2 2025?
Revenue missed the consensus estimate of $165.7M by $8.9M. EPS missed the consensus estimate of $-0.12 by $0.07.
How did Opko Health's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 13.9% from $182.2M a year earlier and eps declined 1800.0% from $-0.01.
Where can I find Opko Health's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-100891) and the 10-Q periodic report (0000950170-25-100908) directly on SEC EDGAR. The filing index links above go to sec.gov.